NCT02533674View on ClinicalTrials.gov

Multicenter, Open-label, Clinical and Pharmacokinetic Study of PM060184 in Combination With Gemcitabine in Selected Patients With Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

57

Participants

Timeline

Start Date

December 12, 2014

Primary Completion Date

July 11, 2019

Study Completion Date

July 11, 2019

Conditions
Solid Tumors
Interventions
DRUG

Gemcitabine plus PM060184

Trial Locations (2)

10461

New York

Unknown

Madrid

Sponsors

Lead Sponsor

PharmaMar
All Listed Sponsors
lead

PharmaMar

INDUSTRY

NCT02533674 - Multicenter, Open-label, Clinical and Pharmacokinetic Study of PM060184 in Combination With Gemcitabine in Selected Patients With Advanced Solid Tumors | Biotech Hunter | Biotech Hunter